Bradley McGregor, MD, describes if biomarkers help guide treatment in advanced renal cell carcinoma

preview_player
Показать описание
Dr. McGregor, Clinical Director, Dana-Farber Cancer Institute, describes whether biomarkers are able to aid in guiding treatment of advanced renal cell carcinoma
  1. OBRoncology
  2. asco gu
  3. gu20
  4. renal cell
  5. obr
  6. obroncology
Рекомендации по теме
Bradley McGregor, MD, 0:01:01

Bradley McGregor, MD, describes if biomarkers help guide treatment in advanced renal cell carcinoma

Bradley McGregor, MD, 0:02:09

Bradley McGregor, MD, considers the optimal approach to treating newly diagnosed RCC patients

Bradley McGregor, MD, 0:01:13

Bradley McGregor, MD, on mRCC patients whose cancer returns and were previously treated with I-O

Bradley McGregor, MD, 0:01:18

Bradley McGregor, MD, considers strategies for treating 2nd line RCC patients

Bradley McGregor, MD, 0:01:19

Bradley McGregor, MD, on impressions of the oral inhibitor study in renal cell carcinoma patients

Dr. McGregor on 0:00:59

Dr. McGregor on Future Research in mCRPC

Dr. McGregor on 0:02:06

Dr. McGregor on Whether Patients Need Frontline Combinations in RCC

Was Muhammad Ali 0:00:42

Was Muhammad Ali Going to Fight Bruce Lee

Bradley McGregor, MD, 0:01:29

Bradley McGregor, MD, on combo ipilimumab + nivolumab in variant histologies of bladder cancer

Dr. McGregor on 0:01:49

Dr. McGregor on Immunotherapy Combinations in Kidney Cancer

Brock Lesnar On 0:00:38

Brock Lesnar On Meeting Muhammad Ali🐐

Bradley McGregor, MD, 0:01:16

Bradley McGregor, MD, on the data regarding enfortumab in post-platinum + I-O bladder cancer

Dr. McGregor on 0:00:53

Dr. McGregor on Challenges Facing Frontline Treatments for RCC

Bradley McGregor, MD, 0:01:49

Bradley McGregor, MD, discusses Checkmate-214 investigating nivolumab + ipilimumab in RCC patients

Bradley McGregor, MD, 0:01:32

Bradley McGregor, MD, shares presented data investigating atezolizumab and cabozantinib in mCRPC

Current status of 0:01:02

Current status of VEGF inhibitor/immunotherapy combinations in RCC

Dr. McGregor on 0:01:03

Dr. McGregor on the Evolving Treatment Landscape of RCC

Muhammad Ali surprises 0:00:46

Muhammad Ali surprises Sylvester Stallone at the 1977 Oscars👑😂

Nivolumab and ipilimumab 0:01:56

Nivolumab and ipilimumab for advanced BCVH

Muhammad Ali Meets 0:00:35

Muhammad Ali Meets Mike Tyson

Jordan Peterson’s Thoughts 0:02:10

Jordan Peterson’s Thoughts on Andrew Tate

Achieving better response 0:01:31

Achieving better response rates in metastatic RCC

Dr. McGregor on 0:01:16

Dr. McGregor on Combination Therapies With Nivolumab, Cabozantinib, and Sunitinib in RCC

Dr. McGregor on 0:01:47

Dr. McGregor on Choosing a Combination Therapy Regimen in Advanced RCC